References

transplantologiya

Трансплантология

Transplantologiya. The Russian Journal of Transplantation

2074-05062542-0909

IPO Association of Transplantologists

10.23873/2074-0506-2012-0-3-5-14

transplantologiya-347

Research Article

АКТУАЛЬНЫЕ ВОПРОСЫ ТРАНСПЛАНТОЛОГИИ

ACTUAL ISSUES OF TRANSPLANTATION

Выбор метода заместительной почечной терапии у больных с отсроченной функцией трансплантата почки в раннем послеоперационном периоде

The choice of renal replacement therapy in patients with a delayed renal graft function in the early postoperative period

Первакова

Э. И.

Pervakova

E. I.

Эльза Ибрагимовна Первакова

P-elza@yandex.ru

Александрова

И. В.

Alexandrova

I. V.

Балкаров

А. Г.

Balkarov

A. G.

НИИ скорой помощи им. Н.В. СклифосовскогоРоссияSklifosovsky Research Institute for Emergency MedicineRussian Federation

2012

23082018

03514

2018

Первакова Э.И., Александрова И.В., Балкаров А.Г.

Pervakova E.I., Alexandrova I.V., Balkarov A.G.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.jtransplantologiya.ru/jour/article/view/347

Проведен анализ результатов лечения 78 реципиентов с отсроченной функцией трансплантата (ОФТ) почки, что составило 35,3 % всех оперированных больных (из них 41 реципиенту в раннем послеоперационном периоде проводили продленную веновенозную гемодиафильтрацию, 37 – стандартный гемодиализ).

Установлено, что проведение продленной веновенозной гемодиафильтрации в 1-е сут после операции оказывает более выраженное корригирующее влияние на функциональное состояние почечного трансплантата. Более позднее начало заместительной почечной терапии (ЗПТ) выявило не только достоверное удлинение периода олигоанурии, но и увеличение частоты развития острых реакций отторжения у больных, которым проводили стандартный гемодиализ.

The treatment outcome of 78 renal transplant recipients with a delayed graft function has been reviewed that accounts for 35.3 % of all operated patients. In the early postoperative period, 41 of them received a continuous venovenous hemodiafiltration, and 37 received a standard hemodialysis.

A continuous venovenous hemodiafiltration in the initial 24 hours after surgery appeared to make a more pronounced corrective effect on the renal graft function recovery. A later initiation of renal replacement therapy (RRT) was associated with a significantly longer oligoanuria period, and also with an increased incidence of acute rejection in the patients who received a standard hemodialysis.

трансплантация почкиишемически реперфузионный синдромотсроченная функция трансплантатаплазмаферезпродленная веновенозная гемодиафильтрациягемодиализ

kidney transplantationischemia-reperfusion syndromedelayed graft functionplasmapheresis treatmentcontinuous venovenous hemodiafiltrationhemodialysis

References1

Colvin, R.B. Chronic Allograft Nephropathy / R.B. Colvin // N. Engl. J. Med. – 2003. – Vol. 349. – P. 2288– 2290.

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent years / H.U. Meier-Kriesche [et al.] // Am. J. Transplant. – 2004. – Vol. 4. – P. 378–383.

Halloran, P.F. Delayed Graft Fanction:State of the Art / P.F. Halloran, L.G. Hunsicker // Am. J. Transplant. – 2001. – Vol. 1. – P. 115–120.

Delayed graft function in kidney transplantation / N. Perico [et al.] // Lancet. – 2004. – Vol. 364, № 9447. – P. 1814–1827.

Does subclinical rejection contribute to chronic rejection in renal transplant patients? / D.N. Ruch [et al.] // Clin. Transplant. – 1999.–Vol. 13. – P. 441– 446.

Nankivell, B.J. Chronic allograft nephropathy current concepts and future directions / B.J. Nankivell, J.R. Chapman // Transplantation. – 2006. – Vol. 81(5). – P. 643–654.

Shoskes, D.A. Deterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection / D.A. Shoskes, J.M. Cecka // Transplantation.– 1998. – Vol. 66. – P. 1697.

Аменд, В.Дж. Первые два месяца после трансплантации почки / В. Дж. Аменд., Ф. Винченти, С. Дж. Томланович // Рук-во по трансплантации почки / под ред. Г.М. Данович ; пер. с англ. под ред. Я.Г. Мойсюка. – 3-е изд. – М. :Триада, 2004. – C. 192–213.

Трансплантация почки у больных, находящихся на перитонеальном диализе / В.Г. Казимиров [и др.] // Сборник трудов XIII ежегодного Санкт-Петербургского нефрологического семинара. – СПб. : [Б. и.], 2004. – C.78–80.

Dialysis modality and delayed graft function after cadaveric renal transplantation / A.J. Bleyer [et al.] // J. Am. Soc. Nephrol.– 1999. – Vol. 10. – P. 154–159.

Lamiere, N. Impact of peritoneal dialysis on patient and graft outcomes after kidney transplantation / N. Lamiere, W.V. Biesen, R. Vanbolder // Contributions to nephrology. Peritoneal dialysis today / С. Ronco (eds). – Karger. – 2003.–Vol. 140. – P. 226–241

Влияние модальности посттрансплантационного диализа на течение острого канальцевого некроза почечного трансплантата / О.Н. Ветчинникова [и др.] // Нефрология и диализ. – 2006. – т. VIII, № 1. –С. 43–48.

Outcomes of non-heart beating donor allografts to expand the donor pool / D.A. Geller [et al.] // Program and abstracts from the First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation. May 2000. 13–17, Abstract 985. – Chicago : Illinois, 2000.

Four-year experience with cyclosporine for heart and heart-lung transplantation / J.A. Macoviak [et al.] // Transplant. Proc. – 1985. – № 17, (suppl. 2). –P. 97–101.

The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand / M. Takada [et al.] // J. Clin. Invest. – 1997. – Vol. 1, № 99(11). –P. 2682–2690.

Hypothesis: Is renal allograft rejection initiated by the response to injury sustained during the transplant process? / C.Y. Lu [et al.] // Kidney International. – 1999. –Vol. 6 (55). – P. 2157–2168.

Muramatsu, M. Baseline glomerular sclerosis influences morphological changes, but not level of serum creatinine / M. Muramatsu [et al.] // Transplant. Proc. –2005.–Vol.37, N 2. – P. 709–711.

Траилин, А.В. Морфологические предикторы функции почечного аллотрансплантата (ПАТ) в первый год после операции / А.В. Траилин [и др.] // Вестник трансплантологии и искусственных органов. – 2010. – № 1. – С. 21–26.

Porter, K.A. Renal Transplantation, in Pathology of the Kidney / K.A. Porter; ed. R.H. Heptinstall. – Boston : Little, Brown & Co., 1992.– P. 1799–1934.

Delayed graft function, acute rejection, and outcome after cadaveric renal transplantation: The multivariate analysis / C. Troppmann [et al.] // Transplantation. – 1995. –Vol. 59. – P. 962–968.

Коробейникова, Э.Н. Модификация определения продуктов перекисного окисления липидов в реакции с тиобарбитуровой кислотой / Э.Н Коробейникова // Лаб. дело. –1989. –№ 7. – С. 8–9.

A randomized double blind trial of the use of human recombinant superoxide dismutase in renal transplantation / R. Pollak [et al.] // Transplantation. – 1993. –Vol. 55. – P. 57–60.

Land, W. Prevention of reperfusioninduced, free radical-mediated acute endotelial injury by superoxide dismutase as an effective tool to delay/prevent chronic renal allograft failure: a revew / W. Land, J.L. Zweker // Transplant. Proc. – 1997. –Vol. 29(6). – P. 2567–2568.

Trimetazidine prevents renal injury in the isolated perfused pig kidney exposed to prolonged cold ischemia / T. Hauet [et al.] // Transplantation. – 1997. – Vol. 15, 64(7). –P. 1082–1086.

Antioxidative vitamins in prevention of ischemia/reperfusion injury / E. Nagel [et al.] // Int. J. Vitamin. Nutr. Res. – 1997. – Vol. 67 (5). – P. 298–306.

Land, W. The impact of ishemia/ reperfusion injury on specific and nonspecific? Early and late chronic events after organ transplantation / W. Land, K. Messmer // Transplant. Rev. – 1996. – Vol. 10. – P. 108–127.

Antibody to intercellular adhesion molecule 1 protects the kidney against ishemic injury / K.J. Kelly [et al.] // Proc. Natl. Acad. Sci. USA. – 1995. – Vol. 91. – P. 812–816.

Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1 / M. Isobe [et al.] // Science. – 1992. – Vol. 255. – P. 1125–1127.

A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globuline as induction treatment in first kidney transplantation / M. Hourmant [et al.] // Transplantation. – 1996. – Vol. 62. – P. 1565–1570.

A phase 1 trial of immunosupression with anti-ICAM-1 (CD54) mAb in renal allograft recipients / C.E. Haug [et al.] // Transplantation. – 1993. – Vol. 55. – P. 766–773.

Лечение реперфузионного синдрома при трансплантации почки путем проведения плазмафереза / М.М. Каабак [и др.] // Нефрология и диализ. – 2002. – Т. 4, № 2. – С. 106–108.

Каабак, М.М. Использование плазмафереза для коррекции реперфузионной травмы при пересадке почки / М.М. Каабак, В.А. Горяйнов, И.В. Дьяченко // Нефрология и диализ. – 2001. – Т. 3, № 3. – С. 345–353.

Синютин, А.А. Влияние послеоперационного плазмафереза на функцию и внутриорганный кровоток почечного аллотрансплантата : дис. ... канд. мед. наук / А.А. Синютин. – М., 2005. – 134 с.

Траилин, А.В. Исходное состояние донорской почки и риск развития отсроченной и замедленной функции почечного аллотрансплантата / А.В. Траилин, Т.Н. Никоненко, А.С. Никоненко // Вестник трансплантологии и искусственных органов. – 2008. – № 3(41). – С. 13–18.

A phase II randomized, controlled trial of continuous hemofiltration in sepsis / L Cole. [et al.] // Crit. Care Med. – 2002. – Vol. 30. – P. 100–106.

Nikou, G.C. Effect of octreotide administration on serum interleukin-6 (IL-6) levels of patients with acute edematous pancreatitis / G.C. Nikou, E.J. Giamarellos-Bourboulis, P. Grecka // Hepatogastroenterology. – 2004. – № 51(56). – Р. 599–602.

Edelmann, G. Treatment of acute necrotizing pancreatitis through the early surgical ablation of necrotic portions / G. Edelmann, P. Boutelier // Chirurgie. – 1974. – Vol. 100. – P. 155–167.

Ohmoto, K. Serum interleukin-6 and interleukin-10 in patients with acute pancreatitis: clinical implications / K. Ohmoto, S. Yamamoto // Hepatogastroenterology. – 2005. – № 52(64). – Р. 990.

Vaslaki, L. The Impact of Convection in Online Haemodiafiltration on Blood Concentration of Advanced Glycation End Products / L. Vaslaki [et al.] // Nephrol. Dial. Transplant. – 2002. – Vol. 17, (Suppl. 1) (M383). – P. 154.

Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure / M. Bell [et al.] // Intensive Care Med. – 2007. – Vol. 33. –P. 773 –780.

Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury / S. Uchino [et al.] // Int. J. Artif. Organs. – 2007. – Vol. 30. –P. 281–292.

Monique, M. Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury / M. Monique [et al.] // Critical. Care. –2010. – Vol. 14. – P. 221.

Charra, B. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment / B. Charra, C. Chazot // Nephrol. Physiol. – 2003. – Vol. 93. – P. 94–101.

Schroeder, K.L. Continuous haematocrit monitoring during intradialytic hypotension:precipitous decline in plasma refill rates / K.L. Schroeder, J. Sallustio E., E.A. Ross // Nephrol. Dial. Transplant. –2004. – Vol. 19. – P. 652–656.

Palevsky, P.M. Intensity of renal support in critically ill patients with acute kidney injury: The VA/NIH Acute Renal Failure Network / P.M. Palevsky [et al.] // N. Engl. J. Med. – 2008. – Vol. 359. – P. 7–20.

Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a andomized clinical trial / R.L. Lins [et al.] // Nephrol. Dial. Transplant. – 2009. – Vol. 24. – P. 512–518.

Influence of dialysis dose on outcome in AKI patients: results of SHARF4 study. Abstracts of the ASN Renal week 2005. November 8–13 / R.L. Lins [et al.]. – Philadelphia : [S. i.], 2005.

Intensities of renal replacement therapy in acute kidney injury: a systematic review and metaanalysis / M. Jun [et al.] // Clin. J. Am. Soc. Nephrol. – 2010. – Vol. 5. – P. 956–963.

Does continuous veno-venous hemodiafiltration therapy reduce mortality due to acute renal failure as compared to intermittent hemodialysis? / V. Barrio [et al.] // Nefrologia. – 2007. – Vol. 27, Suppl. 1. – P. 8–42.

Impact of acute rejection and early allograft function on renal allograft survival / F.G. Cosio [et al.] // Transplantation. – 1997. – Vol. 63. – P. 1611–1615.

The authors declare that there are no conflicts of interest present.